Three specialists in multiple myeloma care share their experiences that may help other providers and patients move smoothly through this time of transition while maintaining high quality care.
As COVID-19 vaccinations increase, mask mandates recede, and pandemic-related restrictions ease, multiple myeloma care teams and patients are moving through transitioning environments—in the clinic, at home, and in their community.
In this episode, three specialists in multiple myeloma care share their experiences that may help other providers and patients move smoothly through this time of transition while maintaining high quality care. The providers discuss their perspectives on added drivers of patient stress, treatment adherence, in-clinic and virtual visits, vaccination for patients with myeloma, apps for managing medication-related changes, connecting patients with specialists via telehealth, and more
"Vaccination in myeloma patients has always been a fairly tricky field. By definition, their immune system doesn't work well, and doesn't make useful antibodies particularly well. In general, we are advising all patients to try and get the vaccine even though the response will be variable." —Adriana Rossi, MD, MSc
Guests:
Parameswaran Hari, MD, MRCP, MS
Armand J. Quick/William F. Stapp Professor of Hematology
Chief, Division of Hematology Oncology
Medical College of Wisconsin
Adriana Rossi, MD, MSc
Associate Director, Myeloma Center
Weill Cornell Medicine
Jessica Unzaga, PharmD, BCPS, BCOP
Pharmacy Clinical Coordinator
Miami Cancer Institute, Baptist Health South Florida
This podcast is produced as part of the “Returning to Practice in the Post-COVID-19 Era: Hematology Disease Education” program. Funding & support provided by AbbVie. Learn more at accc-cancer.org/projects/returning-to-practice/overview
Podcasts:
Webinars:
Publications:
The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Cancer Care Centers.
June 30, 2026
Understanding both the benefits to be had from offering BsAb therapy to its community and the scope of this undertaking, Vanderbilt-Ingram Cancer Center took a novel approach with its APP-led BsAb step-up dosing clinic, which won the program a 2026 ACCC Innovator Award.
